This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

Rogue immune cell that can cause poor antibody responses in chronic viral infections discovered

Myeloid immune cells
Myeloid immune cells alongside red blood cells in an electron micrograph of human blood. Credit: National Cancer Institute

Australian researchers have discovered a previously unknown rogue immune cell that can cause poor antibody responses in chronic viral infections. The finding, published in the journal, Immunity, may lead to earlier intervention and possibly prevention of some types of viral infections such as HIV or hepatitis.

One of the remaining mysteries of the human immune system is why a certain cell, called a B cell, which retains a memory for past infections—ensuring we fight off diseases we have experienced before—often only has a weak capacity to protect us from persistent infections.

Researchers from the Monash University Biomedicine Discovery Institute have essentially solved this mystery by discovering how chronic viral infection induces a previously unknown immune B memory cell that does not produce high levels of antibody.

Importantly the research team, led by Professor Kim Good-Jacobson and Dr. Lucy Cooper, also determined the most effective time during the for therapeutics such as anti-viral and to better boost immune memory cell development.

"What we discovered was a previously unknown cell that is produced by chronic viral infection. We also determined that with therapeutics was the most effective to stop this type of memory cell being formed, whereas late intervention could not," Professor Good-Jacobson said.

According to Dr. Cooper, have been known to alter our ability to form effective long-term protective antibody responses, but how that happens is unknown.

"In the future, this research may result in new therapeutic targets, with the aim to reduce the devastating effect of chronic infectious diseases on global health, specifically those that are not currently preventable by vaccines," she said.

"Revealing this new immune cell type, and what genes it expresses, allows us to determine how we can target it therapeutically and whether that will lead to better antibody responses."

The research team is also looking to see whether this population is a feature of long COVID, which results in some people having a reduced capacity to fight off the symptoms of COVID infection long after the virus has dissipated.

More information: Type I interferons induce an epigenetically distinct memory B cell subset in chronic viral infection, Immunity (2024). DOI: 10.1016/j.immuni.2024.03.016. www.cell.com/immunity/fulltext … 1074-7613(24)00137-7

Journal information: Immunity
Provided by Monash University
Citation: Rogue immune cell that can cause poor antibody responses in chronic viral infections discovered (2024, April 8) retrieved 15 June 2024 from https://medicalxpress.com/news/2024-04-rogue-immune-cell-poor-antibody.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Potential therapeutic pathway to clear chronic viral infections

25 shares

Feedback to editors